These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


651 related items for PubMed ID: 19266397

  • 21. Local and disseminated infections caused by Mycobacterium marinum: an unusual cause of subcutaneous nodules.
    Adhikesavan LG, Harrington TM.
    J Clin Rheumatol; 2008 Jun; 14(3):156-60. PubMed ID: 18525435
    [Abstract] [Full Text] [Related]

  • 22. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab.
    Esser AC, Abril A, Fayne S, Doyle JA.
    J Am Acad Dermatol; 2004 May; 50(5 Suppl):S75-7. PubMed ID: 15097933
    [Abstract] [Full Text] [Related]

  • 23. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M.
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Neurological complications of infliximab.
    Jarand J, Zochodne DW, Martin LO, Voll C.
    J Rheumatol; 2006 May; 33(5):1018-20. PubMed ID: 16511935
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L, Nedorost S, Mirmirani P.
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Mycobacterium mucogenicum: report of a skin infection associated with etanercept.
    Shehan JM, Sarma DP.
    Dermatol Online J; 2008 Jan 15; 14(1):5. PubMed ID: 18319022
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
    Lourari S, Prey S, Livideanu C, Jamard B, Lamant L, Cantagrel A, Paul C.
    J Eur Acad Dermatol Venereol; 2009 Aug 15; 23(8):967-8. PubMed ID: 19192017
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cutaneous mucormycosis complicating methotrexate, prednisone, and infliximab therapy.
    Gadadhar H, Hawkins S, Huffstutter JE, Panda M.
    J Clin Rheumatol; 2007 Dec 15; 13(6):361-2. PubMed ID: 18176152
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice.
    Neven N, Vis M, Voskuyl AE, Wolbink GJ, Nurmohamed MT, Dijkmans BA, Lems WF.
    Ann Rheum Dis; 2005 Apr 15; 64(4):645-6. PubMed ID: 15769924
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 33.